Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
09/2003
09/04/2003US20030165494 Rheumatic diseases; anticholesterol agents; cardiovascular disorders; multiple sclerosis
09/04/2003US20030165489 Method of treating rhinitis or sinusitis
09/04/2003US20030165460 Proteins which control cell differentiation; immunology response; antiinflammatory agents; wound healing agents
09/04/2003US20030165444 Lipochroman-6 as no-synthase inhibitor and uses
09/04/2003CA2513190A1 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors
09/04/2003CA2477634A1 Crystalline anhydrous and monohydrate benzoate salts of (2's,3s)-3-hydroxy-n-{2{n-methyl-n-4-(n-propylamino-carbonyl)phenyl]amino-2-phenyl}-ethylpyrrolidine
09/04/2003CA2477558A1 N-{5-[4-(4-methyl-piperazino-methyl)­-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents
09/04/2003CA2477178A1 Administration of agents for the treatment of inflammation
09/04/2003CA2477111A1 Use of tyrosine kinase inhibitors for treating cns disorders
09/04/2003CA2477105A1 Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
09/04/2003CA2477008A1 Substituted pyrimidinones and pyrimidinthiones
09/04/2003CA2476896A1 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
09/04/2003CA2476630A1 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use thereof
09/04/2003CA2476518A1 Compositions and methods for the treatment of immune related diseases
09/04/2003CA2476173A1 Arylsulfone derivatives
09/03/2003EP1340979A2 Neuropeptide receptor and uses thereof
09/03/2003EP1340811A2 Antibodies with specificity for multiple adhesion molecules
09/03/2003EP1340754A1 Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
09/03/2003EP1340505A2 Therapeutic use of cis-element decoys in vivo
09/03/2003EP1340486A1 Use of sugar esters
09/03/2003EP1339834A2 Enzymes
09/03/2003EP1339748A2 G-protein coupled receptors
09/03/2003EP1339737A2 Immunomodulatory protein derived from the yaba monkey tumor virus
09/03/2003EP1339729A2 Anti-inflammatory compounds derived from pseudopterogorgia elisabethae
09/03/2003EP1339721A2 Hydroxyesters of 7-desmethylrapamycin
09/03/2003EP1339719A1 Benzimidazole derivatives, preparation and therapeutic use thereof
09/03/2003EP1339718A1 Hydantoin compounds useful as anti-inflammatory agents
09/03/2003EP1339717A1 Novel carbamate-substituted pyrazolopyridine derivatives
09/03/2003EP1339716A1 Novel lactame-substituted pyrazolopyridine derivatives
09/03/2003EP1339715A2 Heterocyclic ether substituted imidazoquinolines
09/03/2003EP1339714A1 Novel sulfonamide-substituted pyrazolopyridine derivatives
09/03/2003EP1339712A1 3-substituted quinuclidines and their use as nicotinic agonists
09/03/2003EP1339711A1 Aminothiazoles and their use as adenosine receptor antagonists
09/03/2003EP1339710A1 3-oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives
09/03/2003EP1339709A1 Farnesyl transferase inhibiting benzoheterocyclic derivatives
09/03/2003EP1339708A2 Indole-type inhibitors of p38 kinase
09/03/2003EP1339698A2 Pyrimidine derivatives
09/03/2003EP1339694A1 Substituted 2-phenylaminoimidazoline phenyl ketone derivatives as ip antagonists
09/03/2003EP1339691A1 Novel compounds
09/03/2003EP1339689A1 N-type calcium channel antagonists for the treatment of pain
09/03/2003EP1339687A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents
09/03/2003EP1339680A1 Substituted oxindole derivatives as tyrosine kinase inhibitors
09/03/2003EP1339679A1 3-arylindole derivatives and their use as cb2 receptor agonists
09/03/2003EP1339670A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
09/03/2003EP1339665A1 Nitroderivatives as drugs for diseases having an inflammatory basis
09/03/2003EP1339663A2 Naphthalene derivatives
09/03/2003EP1339458A2 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity
09/03/2003EP1339411A2 Use of bisphosphonates for pain treatment
09/03/2003EP1339405A1 Use of anti-muscarinic agents and calcium channel blockers in combination
09/03/2003EP1339402A2 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors
09/03/2003EP1339392A2 Solid polyunsaturated fatty acid compositions
09/03/2003EP1339385A1 Skin cream stimulating the surface bloodstream
09/03/2003EP1339294A1 Nutritional composition for an immune condition
09/03/2003EP1250045B1 Particulate blends and compacted products formed therefrom, and the preparation thereof
09/03/2003EP1140048B1 Use of naaladase inhibitors for the manufacture of a medicament for the treatment of certain diseases
09/03/2003EP1077947B1 Novel 1,5 and 3-o-substituted 1h-indazoles with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as medicaments
09/03/2003EP0977741B1 Substituted phenyl derivatives, their preparation and use
09/03/2003EP0977733B1 Arylsulfonylamino hydroxamic acid derivatives
09/03/2003EP0934271B1 Substituted arylalkylamines as neurokinin antagonists
09/03/2003EP0797435B1 Controlled release matrix for pharmaceuticals
09/03/2003EP0765172B1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin
09/03/2003EP0612318B1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
09/03/2003CN1440424A Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof
09/03/2003CN1440412A Thienopyrrolidinones
09/03/2003CN1440411A Aryl and heteroaryl diazabicycloalkanes, their preparation and use
09/03/2003CN1440409A Multicyclic compounds and the use as inhibitors of PARP, VEGFR2 and MLK3 enzymes
09/03/2003CN1440408A Inhibitors of human phosphatidyl-inositol 3-kinase delta
09/03/2003CN1440402A N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity
09/03/2003CN1440400A Bicyelyl or heterobicyclylmethanesulfonylamino-substituted N-hydroxyformamides
09/03/2003CN1440396A Colchinol derivatives as angiogenesis inhibitors
09/03/2003CN1440395A COLCHINOL derivatives as vascular damaging agents
09/03/2003CN1440392A Phenylpyridazine derivatives and drugs containing the same
09/03/2003CN1440383A PPARγ调制剂 PPARγ modulators
09/03/2003CN1440295A Vaccine comprising active agent immunogenic acyl glyceryl phosphatidylinositol monno-oligosaccharide
09/03/2003CN1440291A Pharmaceutical composition based on non-steroid anti-inflammatory agent
09/03/2003CN1440287A Method of treating peripheral vascular diseases, peripheral neuropathies, and automatic neuropathies
09/03/2003CN1440276A Use of oligosaccharides to stimulate beta-endorphin production
09/03/2003CN1439651A Recombined human CD11a monoclone antibody and its preparation and medicinal composition
09/03/2003CN1439648A Loquat leaf triterpene acid composition and its uses in preparation of medicine against inflammation and antitussive
09/03/2003CN1439641A Anti-cancer chemicals of methotrexate derivatives and their uses in pharmaceutical science
09/03/2003CN1439417A External used medicine for traumatic injury and preparation thereof
09/03/2003CN1439399A Blood promoting and bone strenglhening pellets
09/03/2003CN1439387A Purple stem herba lycopi preparation against rheumatism
09/03/2003CN1439385A Chinese medicine for rheumatism
09/03/2003CN1439382A Chinese medicinal herb paste for fractures and preparation thereof
09/03/2003CN1439380A Degradable apisin microballoons injection and preparation thereof
09/03/2003CN1120160C Isoxazole and cortonamide derivatives and their use as pharmaceuticals and disgnositics
09/03/2003CN1119997C Percutaneous tap preparation containing fentanyl
09/02/2003US6613926 Perchloramido phosphonyl reagents and analogs thereof
09/02/2003US6613920 25-(5-propylimidazol-2-yl)-26,27-cyclo-9, 10-secocholesta-5,7,10(19),22-tetraene-1,3,24-triol; antagonizes the action of calcitriol in HL 60 cells; hyperprolifierative diseases of the skin, tumor diseases and precancerous stages
09/02/2003US6613917 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
09/02/2003US6613911 Reaction of haloarylacetic acids or esters with olefins to give vinylarylacetic acids or esters, oxidation with an oxidizing reagent gives formylarylacetic acids or esters
09/02/2003US6613905 Chemokine receptor antagonists and methods of use therefor
09/02/2003US6613874 Melanocortin receptor ligands
09/02/2003US6613801 Method for the synthesis of compounds of formula I and their uses thereof
09/02/2003US6613794 Inhibiting tumor necrosis factor alpha, treating eosinophil-related condition, treating inflammatory airway disorder
09/02/2003US6613790 Prodrugs of COX-2 inhibitors
09/02/2003US6613784 Cyclooxygenase inhibitors such as 2-acetyloxybenzoic acid 6-(nitroxymethyl)-2-methylpyridinyl ester hydrochloride, having good kinetics, solubility and efficiency; nontoxic
09/02/2003US6613778 Imidazopyridine derivatives as phosphodiesterase VII inhibitors
09/02/2003US6613775 Imidazo[1,2-a]pyridine compounds
1 ... 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 ... 1272